Volitionrx (VNRX) Change in Receivables (2012 - 2025)
Volitionrx (VNRX) posted Change in Receivables of $8723.0 for Q4 2025, down 92.7% on a QoQ basis from $119488.0 in Q3 2025, and up 104.32% year-over-year from $4269.3 in Q4 2024.
Volitionrx (VNRX) Change in Receivables (2012 - 2025) Analysis & Trends
Volitionrx's Change in Receivables history runs 7 years deep, the most recent figure standing at $8723.0 for Q4 2025.
- Quarterly Change in Receivables rose 104.32% year-over-year to $8723.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $207234.0 (up 256.94% YoY) and the FY2025 annual result came in at $207234.0, up 256.94% from the prior year.
- Change in Receivables was $8723.0 for Q4 2025 at Volitionrx, down from $119488.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $230928.0 in Q3 2023 and bottomed at -$315079.0 in Q2 2023.
- A 5-year average of $7986.8 and a median of $7139.5 in 2021 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2021 — Change in Receivables tumbled 5783.47% — and 2023, when it surged 7805.31%.
- Volitionrx's Change in Receivables stood at -$24926.0 in 2021, then tumbled by 163.38% to -$65649.0 in 2022, then surged by 305.98% to $135225.0 in 2023, then slumped by 249.41% to -$202037.0 in 2024, then jumped by 104.32% to $8723.0 in 2025.
- Business Quant data shows VNRX's Change in Receivables at $8723.0 in Q4 2025, $119488.0 in Q3 2025, and $1767.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | 8,723.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8,723.00 |
| Dec 31, 2025 | 8,723.00 |
| Sep 30, 2025 | 119,488.00 |
| Sep 30, 2025 | 119,488.00 |
| Jun 30, 2025 | 1,767.00 |
| Jun 30, 2025 | 1,767.00 |
| Mar 31, 2025 | 77,256.00 |
| Mar 31, 2025 | 77,256.00 |
| Dec 31, 2024 | -202,037.00 |
| Dec 31, 2024 | -202,037.00 |
| Sep 30, 2024 | 146,349.00 |
| Sep 30, 2024 | 146,349.00 |
| Jun 30, 2024 | 29,968.00 |
| Jun 30, 2024 | 29,968.00 |
| Mar 31, 2024 | -106,325.00 |
| Mar 31, 2024 | -106,325.00 |
| Dec 31, 2023 | 135,225.00 |
| Dec 31, 2023 | 135,225.00 |
| Sep 30, 2023 | 230,928.00 |
| Sep 30, 2023 | 230,928.00 |